Higher Plasma Soluble Receptor for Advanced Glycation End Products (sRAGE) Levels Are Associated With Incident Cardiovascular Disease and All-Cause Mortality in Type 1 Diabetes: A 12-Year Follow-Up Study

OBJECTIVE: To investigate the associations of plasma levels of soluble receptor for advanced glycation end products (sRAGE) with incident cardiovascular disease (CVD) and all-cause mortality in type 1 diabetes and the extent to which any such associations could be explained by endothelial and renal...

Descripción completa

Detalles Bibliográficos
Autores principales: Nin, Johanna W.M., Jorsal, Anders, Ferreira, Isabel, Schalkwijk, Casper G., Prins, Martin H., Parving, Hans-Henrik, Tarnow, Lise, Rossing, Peter, Stehouwer, Coen D.A.
Formato: Texto
Lenguaje:English
Publicado: American Diabetes Association 2010
Materias:
Complications
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2911054/
https://www.ncbi.nlm.nih.gov/pubmed/20522598
http://dx.doi.org/10.2337/db09-1509

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2911054/
https://www.ncbi.nlm.nih.gov/pubmed/20522598
http://dx.doi.org/10.2337/db09-1509

Ejemplares similares